Search

Your search keyword '"Alwayn, Ian P. J."' showing total 168 results

Search Constraints

Start Over You searched for: Author "Alwayn, Ian P. J." Remove constraint Author: "Alwayn, Ian P. J."
168 results on '"Alwayn, Ian P. J."'

Search Results

1. A cell-free nutrient-supplemented perfusate allows four-day ex vivo metabolic preservation of human kidneys

2. Effective and safe implementation of robot‐assisted donor nephrectomy by experienced laparoscopic surgeons.

3. Chronic Pancreas Allograft Rejection Followed by Successful HLA-Incompatible Islet Alloautotransplantation: A Novel Strategy?

4. Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study

5. The Non-Muscle-Splitting Mini-Incision Donor Nephrectomy Remains a Feasible Technique in the Laparoscopic Era of Living Kidney Donation

6. The role of flavin mononucleotide (FMN) as a potentially clinically relevant biomarker to predict the quality of kidney grafts during hypothermic (oxygenated) machine perfusion.

8. The Non-Muscle-Splitting Mini-Incision Donor Nephrectomy Remains a Feasible Technique in the Laparoscopic Era of Living Kidney Donation.

12. Complement Is Activated During Normothermic Machine Perfusion of Porcine and Human Discarded Kidneys.

13. Evaluation of Liver Graft Donation After Euthanasia.

14. Improving outcomes for donation after circulatory death kidney transplantation: Science of the times

15. Evaluation of Liver Graft Donation After Euthanasia

16. Improving outcomes for donation after circulatory death kidney transplantation: Science of the times

23. Preclinical models versus clinical renal ischemia reperfusion injury: A systematic review based on metabolic signatures

24. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-αGal antibody

27. Joint modeling of liver transplant candidates outperforms the model for end‐stage liver disease: The effect of disease development over time on patient outcome

28. Severe COVID‐19 in a renal transplant recipient: A focus on pharmacokinetics

30. Cryopreservation and mycophenolate therapy are detrimental to hematopoietic progenitor cells

37. Omega-3 Fatty Acid Supplementation Prevents Hepatic Steatosis in a Murine Model of Nonalcoholic Fatty Liver Disease

38. Cryopreservation and mycophenolate therapy are detrimental to hematopoietic progenitor cells

41. Hand-assisted retroperitoneoscopic versus standard laparoscopic donor nephrectomy: HARP-trial.

42. Laparoscopic donor nephrectomy in obese donors: easier to implement in overweight women?

45. MECHANISMS OF THROMBOTIC MICROANGIOPATHY FOLLOWING XENOGENEIC HEMATOPOIETIC PROGENITOR CELL TRANSPLANTATION1

46. Cost and outcome of liver transplantation

47. Evaluation of Minimum-to-Severe Global and Macrovesicular Steatosis in Human Liver Specimens: A Portable Ambient Light-Compatible Spectroscopic Probe.

48. Certification Training and Liver Transplant Experience Improves Liver Procurement Outcomes: The Dutch Approach.

50. Impact of device variability and protocol differences on kidney function during normothermic machine perfusion: A comparative study using porcine and human kidneys.

Catalog

Books, media, physical & digital resources